Palantir to offer cancer analytics under JV deal with Germany’s Merck
From Reuters – December 19th 2018 By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) – Palantir Technologies Inc will set up a cancer data analytics joint venture with German lab supplies company Merck KGaA, as the U.S. analytics and security firm makes further inroads into health care. The new U.S.-based venture, called Syntropy, will offer cancer[…]